Such data were similar to a previous report that DLG5 expression was reduced in CD44+/CD24− population in MCF10A cells.11 Given that down‐regulated DLG5 expression was associated with TAM resistance in breast cancer our findings suggest that DLG5 may inhibit TAM resistance by attenuating the stemness of BCSCs. Here, DLG5 is linked to breast carcinoma.